US biotechnology major Monsanto and one of its group entities have moved Delhi High Court against Competition Commission’s order rejecting their pleas challenging a probe into their top officials’ role in a case relating to alleged unfair business practices in the Indian seeds market.
Justice Sanjeev Sachdeva on Monday listed the matter for hearing on August 31 after advocate Ajit Warrier, appearing for Monsanto, said they were filing an application to add more ground to their challenge to the Competition Commission of India’s July 26 order.
Monsanto and its group company Mahyco Monsanto Biotech have challenged the July 26 decision of the competition regulator on the ground that individuals can be probed only if the company does not comply with orders.
On July 26, CCI had rejected the companies’ review pleas against the regulator’s decision to probe the role of their officers/persons-in-charge. They had contended that it was not permissible for the regulator to issue any directions to look into the role of the persons responsible for the conduct of business unless violation of competition norms was made out.
While rejecting as many as six such applications filed by various Monsanto entities, CCI also asked them to cooperate in the investigation so that the probe is completed “without undue delay”.
Earlier this year, CCI ordered a detailed probe against US-based genetically-modified seed major Monsanto after finding prima facie evidence of violating competition norms.
After ordering probe in February, the regulator clubbed three more complaints against the company in June.
Full Content: Bloomberg
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas